Literature DB >> 11604986

A new in vivo model for studying invasion and metastasis of esophageal squamous cell carcinoma.

T Furihata1, T Sakai, H Kawamata, F Omotehara, Y Shinagawa, J Imura, Y Ueda, K Kubota, T Fujimori.   

Abstract

The aim of our current study was to establish an orthotopic inoculation model for studying invasion and metastasis of esophageal squamous cell carcinoma (SCC). Male BALB/c nude mice were used for the experiment. A midline incision was made from the upper to middle abdomen. The abdominal esophagus was carefully exposed. Human esophageal T.Tn SCC cells or human cervical HeLa SCC cells, were injected into the submucosa of the lower esophagus. One of the mice injected with T.Tn cells was sacrificed at 5 weeks, and the remaining five sacrificed at 13 weeks after inoculation. The mice injected with HeLa cells were sacrificed at 3-4 weeks after inoculation. T.Tn cells and HeLa cells formed tumors at the esophagus, but did not metastasize to lymph nodes or lungs. HeLa cells produced peritoneal implants, and directly invaded the stomach and the liver. In the present study, we established a novel orthotopic inoculation model of esophageal SCC. This system is an appropriate and a useful model for studying invasion and metastasis of esophageal SCC, and can also be used as a model for developing therapeutic strategies for esophageal cancer in vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11604986     DOI: 10.3892/ijo.19.5.903

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression.

Authors:  Zhuan Zhou; Yu-Liang Ran; Hai Hu; Jian Pan; Zhi-Feng Li; Li-Zhao Chen; Li-Chao Sun; Liang Peng; Xi-Lu Zhao; Long Yu; Li-Xin Sun; Zhi-Hua Yang
Journal:  Clin Exp Metastasis       Date:  2008-03-26       Impact factor: 5.150

2.  New orthotopic implantation model of human esophageal squamous cell carcinoma in athymic nude mice.

Authors:  Shuai Song; Dong Chang; Yong Cui; Jian Hu; Min Gong; Kai Ma; Fang Ding; Zhi-Hua Liu; Tian-You Wang
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

3.  A versatile orthotopic nude mouse model for study of esophageal squamous cell carcinoma.

Authors:  Joseph Chok Yan Ip; Josephine Mun Yee Ko; Valen Zhuoyou Yu; Kwok Wah Chan; Alfred K Lam; Simon Law; Daniel King Hung Tong; Maria Li Lung
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

4.  miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53.

Authors:  Ping Zhou; He Dong; Shuqian He; Lei Fang; Nan Jiang; Qing Sun
Journal:  Mol Med Rep       Date:  2017-06-20       Impact factor: 2.952

5.  Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection.

Authors:  Elodie Melsens; Elly De Vlieghere; Benedicte Descamps; Christian Vanhove; Olivier De Wever; Wim Ceelen; Piet Pattyn
Journal:  Oncol Rep       Date:  2017-05-15       Impact factor: 3.906

6.  Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.

Authors:  Hua Tao; Yuan-Yuan Chen; Zong-Wen Sun; Hua-Lin Chen; Ming Chen
Journal:  J Cell Biochem       Date:  2018-04-17       Impact factor: 4.429

7.  Upregulation of PEDF Predicts a Poor Prognosis and Promotes Esophageal Squamous Cell Carcinoma Progression by Modulating the MAPK/ERK Signaling Pathway.

Authors:  Zui Chen; Di Che; Xiaoqiong Gu; Jiamin Lin; Jing Deng; Ping Jiang; Kaixiong Xu; Banglao Xu; Ting Zhang
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

Review 8.  Esophageal Cancer: Insights From Mouse Models.

Authors:  Marie-Pier Tétreault
Journal:  Cancer Growth Metastasis       Date:  2015-08-16

9.  Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model.

Authors:  Shinji Kuroda; Tetsushi Kubota; Katsuyuki Aoyama; Satoru Kikuchi; Hiroshi Tazawa; Masahiko Nishizaki; Shunsuke Kagawa; Toshiyoshi Fujiwara
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.